[{"orgOrder":0,"company":"SF Research Institute, Inc.","sponsor":"Ixoreal Biomed Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Ashwagandha","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"SF Research Institute, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"SF Research Institute, Inc. \/ Ixoreal Biomed Inc.","highestDevelopmentStatusID":"1","companyTruncated":"SF Research Institute, Inc. \/ Ixoreal Biomed Inc."},{"orgOrder":0,"company":"SF Research Institute, Inc.","sponsor":"Agaja Pharma Pvt. Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"","productType":"Plant Extract\/Herbal","year":"2024","type":"Inapplicable","leadProduct":"Ashwagandha","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"SF Research Institute, Inc.","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"SF Research Institute, Inc. \/ Agaja Pharma Pvt. Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"SF Research Institute, Inc. \/ Agaja Pharma Pvt. Ltd."}]

Find Clinical Drug Pipeline Developments & Deals for Ashwagandha

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          SF Research Institute, Inc.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          SF Research Institute, Inc.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          December 04, 2024

                          Lead Product(s) : Ashwagandha

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Sponsor : Agaja Pharma Pvt. Ltd.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          SF Research Institute, Inc.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          SF Research Institute, Inc.

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          January 13, 2023

                          Lead Product(s) : Ashwagandha

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Undisclosed

                          Sponsor : Ixoreal Biomed Inc.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Sutter Health

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Sutter Health

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          September 17, 2019

                          Lead Product(s) : Ashwagandha

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Natreon

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Natreon

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Sensoril

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          March 09, 2011

                          Lead Product(s) : Ashwagandha

                          Therapeutic Area : Psychiatry/Psychology

                          Highest Development Status : Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank